[go: up one dir, main page]

PT1176961E - Sistemas de administracao de nicotina - Google Patents

Sistemas de administracao de nicotina

Info

Publication number
PT1176961E
PT1176961E PT00929696T PT00929696T PT1176961E PT 1176961 E PT1176961 E PT 1176961E PT 00929696 T PT00929696 T PT 00929696T PT 00929696 T PT00929696 T PT 00929696T PT 1176961 E PT1176961 E PT 1176961E
Authority
PT
Portugal
Prior art keywords
nicotine
administration systems
nicotine administration
encapsulated
systems
Prior art date
Application number
PT00929696T
Other languages
English (en)
Inventor
David Leslie Mcneight
Original Assignee
Micap Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micap Plc filed Critical Micap Plc
Publication of PT1176961E publication Critical patent/PT1176961E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT00929696T 1999-05-13 2000-05-11 Sistemas de administracao de nicotina PT1176961E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9911037.1A GB9911037D0 (en) 1999-05-13 1999-05-13 Nicotine delivery service

Publications (1)

Publication Number Publication Date
PT1176961E true PT1176961E (pt) 2004-03-31

Family

ID=10853329

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00929696T PT1176961E (pt) 1999-05-13 2000-05-11 Sistemas de administracao de nicotina

Country Status (12)

Country Link
US (2) US20060120974A1 (pt)
EP (1) EP1176961B1 (pt)
JP (1) JP2002544230A (pt)
CN (1) CN1200711C (pt)
AT (1) ATE253363T1 (pt)
AU (1) AU4769900A (pt)
DE (1) DE60006376T2 (pt)
DK (1) DK1176961T3 (pt)
ES (1) ES2209882T3 (pt)
GB (1) GB9911037D0 (pt)
PT (1) PT1176961E (pt)
WO (1) WO2000069440A2 (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076605A1 (de) * 2001-03-23 2002-10-03 Symrise Gmbh & Co. Kg Verfahren zur herstellung von einkapselungen
CN100334962C (zh) † 2001-11-15 2007-09-05 三荣源有限公司 微囊及含微囊的经口组合物
WO2004037232A1 (en) * 2002-10-24 2004-05-06 Micap Plc. Targeted delivery
GB2395124A (en) * 2002-11-16 2004-05-19 Fluid Technologies Plc Palatable microcapsules
GB2406053B (en) * 2003-09-10 2008-08-20 Micap Plc Antimicrobial composition
BRPI0507031B1 (pt) 2004-01-23 2021-01-19 Eden Research Plc. método para exterminar nematódeos compreendendo a aplicação de uma composição nematocida compreendendo uma partícula oca de glicano que encapsula um componente de terpeno e uso da referida composição nematocida
GB2413563A (en) * 2004-04-27 2005-11-02 Micap Plc Composition comprising a biocide encapsulated within a fungal cell
AU2005234989A1 (en) * 2004-04-27 2005-11-03 Micap Plc Microbial encapsulation
GB2418654A (en) * 2004-09-29 2006-04-05 Micap Plc Microbial encapsulation
SI1753529T1 (sl) 2004-05-20 2013-12-31 Eden Research Plc Sestavki, ki vsebujejo votli delec glukana ali votli delec stene celice, ki enkapsulira komponento terpena, postopki njihove izdelave in uporabe
AU2006321415B2 (en) 2005-11-30 2012-11-08 Cornell University Terpene-containing compositions and methods of making and using them
US9439416B2 (en) 2005-11-30 2016-09-13 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
USD613029S1 (en) * 2007-11-20 2010-04-06 Mars, Incorporated Candy
WO2010083488A2 (en) 2009-01-19 2010-07-22 Rive Technologies, Inc. Introduction of mesoporosity in low si/ai zeolites
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
USD658347S1 (en) * 2011-01-07 2012-05-01 Gottardi B Maia Alexandre Pet treat
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
USD715019S1 (en) * 2013-04-19 2014-10-14 Pawsome Dog Training, LLC Dog treat
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2015183801A1 (en) 2014-05-27 2015-12-03 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
WO2016069740A1 (en) 2014-10-29 2016-05-06 The Regents Of The University Of California Bioactive delivery vehicles
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
CN114656446A (zh) 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
WO2019049049A1 (en) 2017-09-05 2019-03-14 R. J. Reynolds Tobacco Company SALTS, CO-CRYSTALS, AND CO-CRYSTAL COMPLEXES OF NICOTINE SALTS
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
EP3807260B1 (en) 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Purification of nicotine
USD920628S1 (en) 2019-11-26 2021-06-01 Canopy Growth Corporation Confectionery product
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
JP2024509922A (ja) 2021-03-09 2024-03-05 ニコベンチャーズ トレーディング リミテッド 経口製品及び製造の方法
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
EP4333650A1 (en) 2021-05-06 2024-03-13 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
WO2023053062A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral product with a basic amine and an ion pairing agent
CA3238147A1 (en) 2021-11-15 2023-05-19 Christopher Keller Products with enhanced sensory characteristics
JP2025520696A (ja) 2022-06-24 2025-07-03 ニコベンチャーズ トレーディング リミテッド 受容体調節剤を含む口腔組成物
EP4598367A1 (en) 2022-10-07 2025-08-13 Nicoventures Trading Limited Oral product
EP4598366A1 (en) 2022-10-07 2025-08-13 Nicoventures Trading Limited Oral product
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074839A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024095163A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
JP2025535900A (ja) 2022-11-04 2025-10-30 ニコベンチャーズ トレーディング リミテッド 経口製品
EP4672985A1 (en) 2023-02-28 2026-01-07 Nicoventures Trading Limited Caffeine-containing oral product
GB202304445D0 (en) 2023-03-27 2023-05-10 Nicoventures Trading Ltd Oral product
GB202307279D0 (en) 2023-05-16 2023-06-28 Nicoventures Trading Ltd Oral product
GB202307278D0 (en) 2023-05-16 2023-06-28 Nicoventures Holdings Ltd Oral product
EP4585055A1 (en) 2024-01-12 2025-07-16 Nicoventures Trading Limited Oral product with probiotic component
EP4599698A1 (en) 2024-02-07 2025-08-13 Nicoventures Trading Limited Products comprising sensory agents
EP4602929A1 (en) 2024-02-19 2025-08-20 Nicoventures Trading Limited Oral product with powder coating
EP4623708A1 (en) 2024-03-26 2025-10-01 Nicoventures Trading Limited Sweetener composition for pouched oral products
EP4623702A1 (en) 2024-03-27 2025-10-01 Nicoventures Trading Limited Oral product
EP4631502A1 (en) 2024-04-12 2025-10-15 Nicoventures Trading Limited Use of flavones such as quercetin to increase cognitive function and to reduce jitterness
WO2026013602A1 (en) 2024-07-10 2026-01-15 Rai Strategic Holdings, Inc. Oral products

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) * 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5830463A (en) * 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
GB2299756A (en) * 1995-03-29 1996-10-16 Gilbert Falkingham Clayton Gelatinous pastille containing nicotine
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen

Also Published As

Publication number Publication date
WO2000069440A2 (en) 2000-11-23
WO2000069440A3 (en) 2001-04-05
US20060120974A1 (en) 2006-06-08
GB9911037D0 (en) 1999-07-14
ES2209882T3 (es) 2004-07-01
DE60006376T2 (de) 2004-09-09
DK1176961T3 (da) 2004-03-15
CN1367692A (zh) 2002-09-04
ATE253363T1 (de) 2003-11-15
JP2002544230A (ja) 2002-12-24
DE60006376D1 (de) 2003-12-11
CN1200711C (zh) 2005-05-11
EP1176961B1 (en) 2003-11-05
US20070269417A1 (en) 2007-11-22
AU4769900A (en) 2000-12-05
EP1176961A2 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
PT1176961E (pt) Sistemas de administracao de nicotina
BR9801027B1 (pt) sistema de distribuiÇço de medicamentos.
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
DK1115381T3 (da) Indgivelsessystem til proteinformige lægemidler, hvor der anvendes membranmimetika
ATE548029T1 (de) Wirkstoffabgabevorrichtung mit verzögerter freisetzung
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
NO994837L (no) Intravesikal medikamentavleveringssystem
EP0981333A4 (en) INNOVATIVE SYSTEM FOR THE ADMINISTRATION OF ACTIVE MEDICINES BY AN ACOUSTIC PROCEDURE
IT1303444B1 (it) Dispositivo di rilascio di farmaci.
TR28155A (tr) Aktif madde sevk sistemi.
ATE260640T1 (de) Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
EE200000546A (et) Aerosoolistatud toimeaine manustamissüsteem
DE69711045D1 (de) Vitamin c abgabesystem
NL194604B (nl) Implanteerbaar geneesmiddelpompsysteem.
SI1051174T1 (sl) Gastroprotektirane omeprazolne mikrogranule, postopek za pridobivanje le-teh in farmacevtski pripravki
TR27244A (tr) Ilac dagitim aleti.
NO882897D0 (no) Avleveringssystem for legemidler.
ZA200000610B (en) Micro-osmotic controlled drug delivery systems.
DE50013950D1 (de) Arzneistoffträger zur kontrollierten wirkstoffapplikation hergestellt aus lipidmatrix-arzneistoff-konjugaten (lak-partikel)
NL1006015A1 (nl) Toedieninrichting.
DE10192797D2 (de) Drug-Delivery-Systeme
ITTO920561A1 (it) Dispositivo infusore di farmaci, particolarmente per terapie ferrochelanti.
ZA974920B (en) Drug delivery systems.
DK1183061T3 (da) Lægemiddelafgivelsessystem